imiquimod has been researched along with heme in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budbazar, E; Guo, Z; Krafft, PR; Tang, J; Tong, L; Wang, G; Xue, F; Zhang, JH | 1 |
Chen, H; Dai, Z; Han, L; Huang, H; Li, L; Lu, C; Lu, Y; Wang, A; Wei, J; Zhong, X | 1 |
2 other study(ies) available for imiquimod and heme
Article | Year |
---|---|
TLR7 (Toll-Like Receptor 7) Facilitates Heme Scavenging Through the BTK (Bruton Tyrosine Kinase)-CRT (Calreticulin)-LRP1 (Low-Density Lipoprotein Receptor-Related Protein-1)-Hx (Hemopexin) Pathway in Murine Intracerebral Hemorrhage.
Topics: Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Blood-Brain Barrier; Brain; Brain Edema; Calreticulin; Cerebral Hemorrhage; Enzyme Inhibitors; Heme; Hemopexin; Imiquimod; Low Density Lipoprotein Receptor-Related Protein-1; Membrane Glycoproteins; Mice; Nitriles; Oligodeoxyribonucleotides; Receptors, LDL; Signal Transduction; Thapsigargin; Toll-Like Receptor 7; Tumor Suppressor Proteins | 2018 |
Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Disease Models, Animal; Genistein; Heme; Humans; Imiquimod; Inflammation Mediators; Keratinocytes; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Psoriasis; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A | 2019 |